VARIVAX is a Subcutaneous Injection, Powder, Lyophilized, For Suspension in the Vaccine category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Varicella-zoster Virus Strain Oka/merck Live Antigen.
| Product ID | 0006-4827_325565a6-7cd4-49e9-a628-fa338c0f7d0e |
| NDC | 0006-4827 |
| Product Type | Vaccine |
| Proprietary Name | VARIVAX |
| Generic Name | Varicella Virus Vaccine Live |
| Dosage Form | Injection, Powder, Lyophilized, For Suspension |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 1995-03-17 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103552 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN |
| Active Ingredient Strength | 1350 [PFU]/.5mL |
| Pharm Classes | Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [CS],Chickenpox Vaccine [CS],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 1995-03-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA103552 |
| Product Type | VACCINE |
| Billing Unit | EA |
| Marketing Start Date | 1995-03-17 |
| Marketing Category | BLA |
| Application Number | BLA103552 |
| Product Type | VACCINE |
| Billing Unit | EA |
| Marketing Start Date | 2013-01-17 |
| Ingredient | Strength |
|---|---|
| VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN | 1350 [PFU]/.5mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-4826 | VARIVAX | Varicella Virus Vaccine Live |
| 0006-4827 | VARIVAX | Varicella Virus Vaccine Live |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VARIVAX 73509696 1340022 Live/Registered |
MERCK & CO., INC. 1984-11-19 |